Form 4 for HAE HAEMONETICS CORP

Accepted 2024-05-21 00:00:00 ET · period of report 2024-05-17 · accession 0001127602-24-016173 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-05-21	2024-05-17	HAE	Miller Laurie A.	SVP, Human Resources	F - Tax	$95.73	-76	14.1K	-0.5%	-$7,275
D	2024-05-21	2024-05-17	HAE	Miller Laurie A.	SVP, Human Resources	A - Grant	—	+2,089	16.2K	+15%	—
D	2024-05-21	2024-05-17	HAE	Miller Laurie A.	SVP, Human Resources	A - Grant	$0.00	+4,591	4,591	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-05-17	F	D	76	$95.73	14,084	D	—	—	(F1) Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I. (F2) This number includes unvested RSUs previously reported.
2	Common	Common Stock	2024-05-17	A	A	2,089	—	16,173	D	—	—	(F3) The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant. (F4) Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. (F2) This number includes unvested RSUs previously reported.
3	Derivative	Non-qualified Stock Option (Right to Buy)	2024-05-17	A	A	4,591	$0.00	4,591	D	$95.73 · — to 2031-05-17	4,591 Common Stock	(F5) Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.